Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Repka

Showing results (591-600 of 668) with videos related to

Pageof 67
Sort By:
Ophthalmology|September 8, 2024
Myopic Shift over 5 Years after Pediatric Lensectomy with Primary Intraocular Lens Implantation, Alejandra G de Alba Campomanes, Michael X Repka, et al.
Bone Marrow Transplantation|July 3, 2003
IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trialL J Burns, D J Weisdorf, T E DeFor, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|November 24, 2011
Stereoacuity in children with anisometropic amblyopiaDavid K Wallace, Elizabeth L Lazar, Michele Melia, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|July 30, 2025
Ophthalmic outcomes five years after lensectomy among children with Down syndromeAlejandra G de Alba Campomanes, Michael X Repka, Rui Wu, et al.
Frontiers in Oncology|April 18, 2022
Rationale for Utilization of Hydrogel Rectal Spacers in Dose Escalated SBRT for the Treatment of Unfavorable Risk Prostate CancerMichael C Repka, Michael Creswell, Jonathan W Lischalk, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|April 9, 2013
Feasibility of a clinical trial of vision therapy for treatment of amblyopiaDon W Lyon, Kristine Hopkins, Raymond H Chu, et al.
Ophthalmology|November 13, 2007
Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years, Michael X Repka, Danielle L Chandler, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|August 13, 2008
A randomized trial of atropine vs patching for treatment of moderate amblyopia: follow-up at age 10 years, Michael X Repka, Raymond T Kraker, et al.
Journal of Drug Delivery Science and Technology|April 28, 2015
Mefenamic acid taste-masked oral disintegrating tablets with enhanced solubility via molecular interaction produced by hot melt extrusion technologySultan M Alshehri, Jun-Bom Park, Bader B Alsulays, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|May 16, 2007
Stability of visual acuity improvement following discontinuation of amblyopia treatment in children aged 7 to 12 yearsRichard W Hertle, Mitchell M Scheiman, Roy W Beck, et al.
Pageof 67

Showing results (591-600 of 668) with videos related to

Sort By:
Pageof 67
Ophthalmology|September 8, 2024
Myopic Shift over 5 Years after Pediatric Lensectomy with Primary Intraocular Lens Implantation, Alejandra G de Alba Campomanes, Michael X Repka, et al.
Bone Marrow Transplantation|July 3, 2003
IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trialL J Burns, D J Weisdorf, T E DeFor, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|November 24, 2011
Stereoacuity in children with anisometropic amblyopiaDavid K Wallace, Elizabeth L Lazar, Michele Melia, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|July 30, 2025
Ophthalmic outcomes five years after lensectomy among children with Down syndromeAlejandra G de Alba Campomanes, Michael X Repka, Rui Wu, et al.
Frontiers in Oncology|April 18, 2022
Rationale for Utilization of Hydrogel Rectal Spacers in Dose Escalated SBRT for the Treatment of Unfavorable Risk Prostate CancerMichael C Repka, Michael Creswell, Jonathan W Lischalk, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|April 9, 2013
Feasibility of a clinical trial of vision therapy for treatment of amblyopiaDon W Lyon, Kristine Hopkins, Raymond H Chu, et al.
Ophthalmology|November 13, 2007
Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years, Michael X Repka, Danielle L Chandler, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|August 13, 2008
A randomized trial of atropine vs patching for treatment of moderate amblyopia: follow-up at age 10 years, Michael X Repka, Raymond T Kraker, et al.
Journal of Drug Delivery Science and Technology|April 28, 2015
Mefenamic acid taste-masked oral disintegrating tablets with enhanced solubility via molecular interaction produced by hot melt extrusion technologySultan M Alshehri, Jun-Bom Park, Bader B Alsulays, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|May 16, 2007
Stability of visual acuity improvement following discontinuation of amblyopia treatment in children aged 7 to 12 yearsRichard W Hertle, Mitchell M Scheiman, Roy W Beck, et al.
Pageof 67